H. Manning
Faculty Member
Last active: 3/22/2018

Facile synthesis of SSR180575 and discovery of 7-chloro-N,N,5-trimethyl-4-oxo-3(6-[(18)F]fluoropyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide, a potent pyridazinoindole ligand for PET imaging of TSPO in cancer.

Cheung YY, Nickels ML, Tang D, Buck JR, Manning HC
Bioorg Med Chem Lett. 2014 24 (18): 4466-4471

PMID: 25172419 · PMCID: PMC4163096 · DOI:10.1016/j.bmcl.2014.07.091

A novel synthesis of the translocator protein (TSPO) ligand 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide (SSR180575, 3) was achieved in four steps from commercially available starting materials. Focused structure-activity relationship development about the pyridazinoindole ring at the N3 position led to the discovery of 7-chloro-N,N,5-trimethyl-4-oxo-3(6-fluoropyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide (14), a novel ligand of comparable affinity. Radiolabeling with fluorine-18 ((18)F) yielded 7-chloro-N,N,5-trimethyl-4-oxo-3(6-[(18)F]fluoropyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide ([(18)F]-14) in high radiochemical yield and specific activity. In vivo studies of [(18)F]-14 revealed this agent as a promising probe for molecular imaging of glioma.

Copyright © 2014 Elsevier Ltd. All rights reserved.

MeSH Terms (14)

Acetamides Animals Drug Discovery Glioma Humans Indoles Ligands Male Molecular Imaging Molecular Structure Positron-Emission Tomography Rats Rats, Wistar Receptors, GABA

Connections (1)

This publication is referenced by other Labnodes entities: